Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-29

Clinical Trial Update: Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares transdermal fentanyl and morphine for oral mucositis pain in nasopharyngeal cancer patients undergoing treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Transdermal fentanyl (fentanyl)

Snippet

Sponsor: Jiarong Chen, MD | Conditions: Pain, Nasopharyngeal Carcinoma | Phase 4 | Status: UNKNOWN